RenovoRx, Inc. (RNXT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, RenovoRx, Inc. reported revenue of $1.12M, up 2511.6% from the prior year. The company ran a net loss, with a net margin of -994.5% and a gross margin of 70.9%. It held $8.10M in total assets against $2.67M in total liabilities.
Key ratios (FY2025)
70.9%
Gross margin
-1114.0%
Operating margin
-994.5%
Net margin
-206.0%
Return on equity
+2511.6%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.12M | $43.0K | — | — | — | — | — |
| Cost of Revenue | $327.0K | $0 | — | — | — | — | — |
| Gross Profit | $796.0K | $43.0K | — | — | — | — | — |
| Operating Income | -$12.51M | -$10.97M | -$11.40M | -$9.95M | -$5.67M | -$3.20M | — |
| Net Income | -$11.17M | -$8.81M | -$10.23M | -$9.89M | -$6.32M | -$3.80M | — |
| EPS (Diluted) | $-0.32 | $-0.40 | $-0.99 | $-1.09 | $-1.21 | — | — |
| Total Assets | $8.10M | $8.12M | $1.47M | $7.26M | $16.29M | $1.91M | — |
| Total Liabilities | $2.67M | $3.64M | $4.47M | $1.10M | $938.0K | $4.12M | — |
| Shareholders' Equity | $5.42M | $4.48M | $3.00M | $6.16M | $15.35M | -$14.66M | -$10.93M |
| Cash & Equivalents | $7.02M | $7.15M | $1.17M | $4.39M | $15.19M | $1.79M | — |
| Operating Cash Flow | -$10.97M | -$9.12M | -$10.26M | -$8.81M | -$5.92M | -$3.53M | — |
| Capital Expenditures | $2.0K | $12.0K | — | — | — | — | — |
| Shares Outstanding | 36.61M | 24.03M | 10.69M | 9.10M | 8.93M | 2.23M | — |